Arpita Bhatt

PhD scholar @PGIMER Chd | Academic Researcher | Gut microbiome| Organoids | Antimicrobial Resistance | ResPharm

[Arpita Bhatt @arpitabhatt119]

And the blame game continues 🫣

[Arpita Bhatt @arpitabhatt119]

@IAF_MCC Who is responsible for such losses 😰

[Arpita Bhatt @arpitabhatt119]

@narendramodi Its such a shame you have nothing to comment on the IAF plane crash

[The Nobel Prize @NobelPrize]

BREAKING NEWS
The Norwegian Nobel Committee has decided to award the 2024 #NobelPeacePrize to the Japanese organisation Nihon Hidankyo. This grassroots movement of atomic bomb survivors from Hiroshima and Nagasaki, also known as Hibakusha, is receiving the peace prize for its efforts to achieve a world free of nuclear weapons and for demonstrating through witness testimony that nuclear weapons must never be used again.

#NobelPrize

[TheLiverDoc™ @theliverdoc]

The shameless Entod Pharmaceuticals thought that by tagging the Prime Minister of India on their medical product's post would mask their intention of misleading 100s of 1000s of people.

Entod Pharmaceuticals made a post that proclaimed that their Indian innovation (Make in India sentiments) called PresVu eye drops would "eliminate" the need for reading glasses.

Firstly, this is not their proprietary product or an Indian innovation. PresVu contains 1.25% of a drug called pilocarpine. Pilocarpine is a drug which helps improve near vision temporarily and is used in people suffering from presbyopia - a refractive error that makes it hard for middle-aged and older adults to see things up close.

The US FDA had already approved conditional use of pilocarpine for presbyopia in adults in 2021 (Abbvie Pharma - Vuity) and 2023 (Orasis Pharma - Qlosi). You should see how those two companies marketed their respective products - by specifying the indication, clearly mentioning the benefits and adverse events and did not make any wild claims at all.

See here: https://t.co/UOtZVyHIj3 and here https://t.co/0rfauZ0Og0

Now see what this shady Indian Pharma company did. First, they tagged the major political figure of the country, put out a brand logo which features a lotus flower (same content as the ruling party's political logo) and then made a wild claim about people "not" needing reading glasses anymore.

And when they were criticized by the Ophthalmology community in India - most criticisms arising from South-India (mostly initiated by Tamil Nadu IMA and fully taken up by @drbabukv) - they were held accountable by the Drugs Controller General of India (DGCI).

The company silently deleted their post. The DGCI started an investigation into Entod Pharma and the Central Drugs Standard Control Organization suspended their permission to market the product till further order.

As far as shamelesness goes, Entod Pharma started blaming the Indian Media. The company mentioned that the opinions and claims printed in news stories did not represent Entod Pharmaceuticals and they blamed the Indian media for blowing up their claim "out of proportion" when in fact, the media, as always, without fact-checking, only reported exactly what the company had themselves claimed in their now deleted post.

By the way, this is the same pharma company that promoted "saffron for eye health" and various other eye diseases through similar misleading ads on their useless saffron product which has absolutely no clinical evidence for benefits in any eye condition.

Healthcare regulation in India is a serious joke.

[Santosh Satbhai @santosh7bhai]

My lab @IiserMohali now has two positions available.
-JRF to work in INDO-French Collaborative project
-Project Assistant to work in a DBT funded project
Walk-in interviews are scheduled on September 3. https://t.co/Htz6Y0tGV6 @DBS_IISERM @sbslab_IISERM Repost Plz.

[M D Madhusudan @mdmadhusudan]

AJT Johnsingh, the man who taught me—and literally hundreds of others—so much about wildlife and nature, is no more. I will miss him.

[Arpita Bhatt @arpitabhatt119]

https://t.co/QYE9eBWL7O

[Arpita Bhatt @arpitabhatt119]

@elonmuskADO No

[Arpita Bhatt @arpitabhatt119]

https://t.co/mbeFwuoinC

Check out

[Advances in IBD @AIBDNetwork]

In honor of #WORLDIBDDAY - Sunday, May 19th, let's raise awareness and show our support to the #IBD community!
If you're interesting in expanding your #IBD education, join us December 9-11 in Orlando for #AIBD2024 Discount Code Available!
Register Today: https://t.co/WcCZy6Q07D

[Arpita Bhatt @arpitabhatt119]

@nirajgupta02 @IISER_BERHAMPUR @iamvivekt @ISMRM @Dee_Kay_Jay @nehayadav1211 Great keep it up

[Arpita Bhatt @arpitabhatt119]

@abhijit_MLab ❤️

[ICGEB, New Delhi @ICGEBNewDelhi]

Vacancy Alert.....!!!
Research Scientist Position at ICGEB New Delhi

[Arpita Bhatt @arpitabhatt119]

Wishing everyone a very happy women's day.
This year let's invest in different activities and grow together !
Did some pottery today at PGIMER, Chandigarh.

Thank you @ArdPgimer for organising the event.
Also, got to meet Urvashi Gulati mam, former chief secretary, Haryana.

[Arpita Bhatt @arpitabhatt119]

@RitikaRajput23 @ARDPGI @ArdPgimer Agreed

[Arpita Bhatt @arpitabhatt119]

Anyways, not the first time!
Really disappointed 😞

[CSIR-IMTech @CSIR_IMTECH]

CSIR-Institute of Microbial Technology, invites applications from exceptionally motivated candidates for pursuing doctoral research at CSIR-IMTECH under the aegis of PhD program being jointly run by CSIR-IMTECH and @AcSIR_India @CSIR_IND
Details: https://t.co/utrBrNnvz5

[All India Research Scholars Association @AIRSAIndia]

#reactivatecsirfellowship
#CsirPhDscholars
The #CSIR_JRF exam is a challenging endeavor. Those who successfully qualify for the CSIR-JRF aim to fulfill their dream of receiving a fellowship during their PhD. However, the termination of the fellowship is perplexing, and it would be beneficial for @CSIRIndia to establish communication with host institutes beforehand to address any potential issues.
@DrNKalaiselvi
@HRDG_CSIR
@DrJitendraSingh @PMOIndia @the_hindu @IndianExpress @TimesNow @TheQuint @Xpress_edex

[Arpita Bhatt @arpitabhatt119]

@DeepakNModi PhD thesis